Said Francis
Chief Business Officer & General Manager, Individualized Neoantigen Therapies Moderna
Seminars
Wednesday 7th October 2026
The New Frontier of Precision Medicine – From Tumor Fingerprint to Dose: Integrating Data & NGS to Power Neoantigen Therapies
9:30 am
Presentation Details to be Announced
